CSF2RB p.Ser625Phe
c.1874C>T · rs560156832 · VCV796279
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1182 | likely benign |
|---|---|---|
| REVEL | 0.383 | indeterminate |
| SaProt | LLR -7.60 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 5.7 | GERP 0.43, phastCons 1 |
| Regional constraint | o/e 1.07 | unconstrained · MANE · 1,937 bp · p 0.11 · regional, not allelic |
| Overall | ||
| CADD | 23.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.18% | 554 |
| Remaining individualsnot grpmax-eligible | 0.015% | 6,686 |
| Finnishnot grpmax-eligible | 0.00337% | 29,699 |
| European (non-Finnish) | 0.0027% | 37,057 |
| East Asian | 0.00243% | 41,162 |
| African / African-American | 0.00136% | 73,328 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CSF2RB
- Protein
- p.Ser625Phe
- Coding
- c.1874C>T
- MANE Select
- NM_000395
- dbSNP
- rs560156832
- Type
- single nucleotide variant
- Location
- chr22:36937682 (GRCh38)
- Gene constraint
- LOEUF 0.511 · pLI 0.93 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 65.50 · 10 PDB
- Residue 625
- the 'disordered' region
Disease context
surfactant metabolism dysfunction, pulmonary, 5 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hereditary pulmonary alveolar proteinosis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Elderly, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- CSF2RB p.Arg211Gln Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Arg461Cys Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Glu533Lys Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Gly845Ser Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Thr196Asn Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Thr50Ile Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Arg215His Benign/Likely benign ★★ same condition
- CSF2RB p.Ala749Pro Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/csf2rb-p-ser625phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown